Treatment of Parkinson's disease with proglumide, a CCK antagonist.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2027496.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proglumide, a cholecystokinin antagonist, did not improve Parkinson's disease in a preliminary drug treatment trial.
Medical subject headings
- Parkinson Disease
- Proglumide